Inventor · disambiguated record
Felix Wussow
Also filed as: WUSSOW FELIX
13 granted patents·7 pending applications·11 citations·filing 2015–2025
86Inventor score
Top patents by PatentIndex Score
20 records- 0188US9931395B2MVA vaccine for delivery of a UL128 complex and preventing CMV infectionHOPE CITY·Filed 2015·Granted Apr 3, 2018·6 cites·20 claims
- 0286US12150987B2MVA vaccine for delivery of a UL128 complex and preventing CMV infectionHOPE CITY·Filed 2023·Granted Nov 26, 2024·0 cites·26 claims
- 0384US10376575B2MVA vaccine for delivery of a UL128 complex and preventing CMV infectionHOPE CITY·Filed 2018·Granted Aug 13, 2019·3 cites·20 claims
- 0481US11964006B2Multivalent Epstein-Barr virus-like particles and uses thereofHOPE CITY·Filed 2018·Granted Apr 23, 2024·2 cites·14 claims
- 0578US12303559B2Multivalent Epstein-Barr virus-like particles and uses thereofHOPE CITY·Filed 2024·Granted May 20, 2025·0 cites·20 claims
- 0674US10842864B2MVA vaccine for delivery of a UL128 complex and preventing CMV infectionHOPE CITY·Filed 2019·Granted Nov 24, 2020·0 cites·10 claims
- 0773US11717568B2MVA vaccine for delivery of a UL128 complex and preventing CMV infectionHOPE CITY·Filed 2020·Granted Aug 8, 2023·0 cites·13 claims
- 0870US2025161435A1Multivalent kaposi sarcoma-associated herpesvirus-like particles and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 0969US11844833B2Expression system for expressing herpesvirus glycoprotein complexesHOPE CITY·Filed 2022·Granted Dec 19, 2023·0 cites·21 claims
- 1062US2025215456A1Poxvirus-based vectors produced by natural or synthetic dna and uses thereofHOPE CITY·Filed 2025·Application pending·0 cites
- 1161US11384137B2MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereofHOPE CITY·Filed 2019·Granted Jul 12, 2022·0 cites·4 claims
- 1261US2023097513A1Poxvirus-based vectors produced by natural or synthetic dna and uses thereofHOPE CITY·Filed 2021·Application pending·0 cites
- 1360US2023323389A1Synthetic modified vaccinia ankara (smva) based coronavirus vaccinesHOPE CITY·Filed 2021·Application pending·0 cites
- 1459US2025235527A1Synthetic modified vaccinia ankara (smva) based coronavirus vaccinesHOPE CITY·Filed 2022·Application pending·0 cites
- 1557US12156911B2Multivalent Kaposi sarcoma-associated herpesvirus-like particles and uses thereofHOPE CITY·Filed 2020·Granted Dec 3, 2024·0 cites·16 claims
- 1657US11389529B2Expression system for expressing herpesvirus glycoprotein complexesHOPE CITY·Filed 2018·Granted Jul 19, 2022·0 cites·17 claims
- 1756US2023233666A1SYNTHETIC MODIFIED VACCINIA ANKARA (sMVA) BASED CORONAVIRUS VACCINESHOPE CITY·Filed 2022·Application pending·0 cites
- 1853US10487139B2MVA-gh/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereofHOPE CITY·Filed 2018·Granted Nov 26, 2019·0 cites·13 claims
- 1952US12054736B2Genetically modified recombinant vaccinia ankara (RMVA) vaccines of improved stability and methods of preparation thereofHOPE CITY·Filed 2020·Granted Aug 6, 2024·0 cites·19 claims
- 2045US2024082403A1Chimeric Antigen Receptors against Human CytomegalovirusUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Felix Wussow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →